Compare iShares China Large-Cap ETF (FXI) vs Revolution Medicines Inc. Common Stock (RVMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares China Large-Cap ETF vs Revolution Medicines Inc. Common Stock — how do they compare? iShares China Large-Cap ETF trades at $34.32 (market cap $3.86B), while Revolution Medicines Inc. Common Stock trades at $186.59 (market cap $40.32B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 10.4× iShares China Large-Cap ETF's market cap, and Revolution Medicines Inc. Common Stock is trading nearer its 52-week high, iShares China Large-Cap ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares China Large-Cap ETF for 149 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| FXI | RVMD | |
|---|---|---|
Market Cap | $3.86B | $40.32B |
Volume | 16,323,837 | 4,855,734 |
52-Week High | $41.08 | $221.15 |
52-Week Low | $31.59 | $47.50 |
Typical Hold Time | 149 Days | 0 Days |
Sector | — | Health |
Enterprise Value | — | $37.02B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FXI, the iShares China Large-Cap ETF, trades at $33.42, down 1.04% with bearish technical signals from moving averages. The ETF faces headwinds from China's economic challenges and trade tensions, though it trades at a significant discount to U.S. equities with a P/E of 11.10 versus the S&P 500's 22.54. Recent geopolitical developments from the Trump-Xi summit and China's export dynamics create mixed sentiment.
The outlook remains cautious with technical indicators signaling selling pressure, while fundamental valuation appears attractive for risk-tolerant investors seeking China exposure. Key risks include ongoing U.S.-China tensions, China's industrial overcapacity, and weak domestic consumption that could limit upside potential despite the valuation discount.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About iShares China Large-Cap ETF
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The index designed to measure the performance of the largest companies in the Chinese equity market that trade on the Stock Exchange of Hong Kong and are available to international investors. The fund is non-diversified.
Read more on FXI →About Revolution Medicines Inc. Common Stock
Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →
